Page last updated: 2024-08-24

trofosfamide and Soft Tissue Neoplasms

trofosfamide has been researched along with Soft Tissue Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dörken, B; Kretzschmar, A; Pink, D; Reichardt, P; Thuss-Patience, PC; Tilgner, J1
Egerer, G; Ho, AD; Kasper, B1
Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J1

Trials

1 trial(s) available for trofosfamide and Soft Tissue Neoplasms

ArticleYear
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine

2008

Other Studies

2 other study(ies) available for trofosfamide and Soft Tissue Neoplasms

ArticleYear
Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis.
    Onkologie, 2002, Volume: 25, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms

2002
A new therapeutic approach in patients with advanced sarcoma.
    International journal of clinical oncology, 2005, Volume: 10, Issue:6

    Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Female; Humans; Lactones; Male; Middle Aged; Neovascularization, Pathologic; Palliative Care; Pilot Projects; Pioglitazone; Sarcoma; Soft Tissue Neoplasms; Sulfones; Thiazolidinediones; Treatment Outcome

2005